Back to Superinvestors
SUPERINVESTOR HOLDERS
TMO
Thermo Fisher Scientific Inc
Healthcare · Diagnostics & Research
- Holders
- 16
- Total value
- $5,745,966,380
- Total shares
- 11,461,387
- Cross-link
- Financials →
| Investor | Shares | Value | % of Portfolio | Activity | As of |
|---|---|---|---|---|---|
|
Dodge & Cox
Dodge & Cox
|
3,054,778 | $1,531,543,498 | 0.80% | ADD +3,029,037 | 30 Jun 2026 |
|
PRIMECAP Management
PRIMECAP Management Co
|
1,982,271 | $993,831,390 | 0.59% | REDUCE -260 | 30 Jun 2026 |
|
Andreas Halvorsen
Viking Global Investors
|
1,937,415 | $971,342,384 | 2.77% | ADD +269,390 | 30 Jun 2026 |
|
Hersh Cohen
ClearBridge Investments
|
1,691,069 | $847,834,531 | 0.70% | ADD +80,372 | 30 Jun 2026 |
|
Tom Steyer
Farallon Capital Management LLC
|
1,049,185 | $526,019,392 | 2.44% | ADD +167,700 | 30 Jun 2026 |
|
Larry Robbins
Glenview Capital Management
|
627,240 | $314,473,046 | 5.73% | ADD +376,715 | 30 Jun 2026 |
|
Cliff Asness
AQR Capital Management
|
257,910 | $128,991,084 | 0.04% | ADD +132,228 | 30 Jun 2026 |
|
Ric Dillon
Diamond Hill Capital Management
|
252,559 | $126,622,980 | 1.01% | REDUCE -108,093 | 30 Jun 2026 |
|
Steven Romick
First Pacific Advisors
|
248,244 | $124,459,612 | 1.56% | ADD +26,348 | 30 Jun 2026 |
|
Joel Greenblatt
Gotham Asset Management
|
139,499 | $69,939,219 | 0.16% | ADD +37,434 | 30 Jun 2026 |
|
Wallace Weitz
Weitz Investment Management
|
115,200 | $57,756,672 | 4.00% | REDUCE -5,800 | 30 Jun 2026 |
|
Tom Gayner
Markel Group Inc.
|
73,100 | $36,649,416 | 0.28% | ADD +6,000 | 30 Jun 2026 |
|
Stanley Druckenmiller
Duquesne Family Office
|
19,200 | $9,626,000 | 0.18% | NEW +19,200 | 30 Jun 2026 |
|
Ron Baron
Baron Capital (BAMCO)
|
9,219 | $4,622,038 | 0.01% | REDUCE -14,451 | 30 Jun 2026 |
|
Mario Gabelli
GAMCO Investors
|
4,060 | $2,035,522 | 0.02% | REDUCE -473 | 30 Jun 2026 |
|
Murray Stahl
Horizon Kinetics LLC
|
438 | $219,596 | 0.00% | HOLD | 30 Jun 2026 |